Go Pro
→ Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid (From Altimetry) (Ad)tc pixel Free ICCM Stock Alerts

IceCure Medical (ICCM) Competitors

IceCure Medical logo
$2.14 +0.03 (+1.42%)
Closing price 09/10/2026 04:00 PM Eastern
Extended Trading
$2.13 -0.01 (-0.47%)
As of 05:49 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

ICCM vs. ARAY, IINN, MODD, QTEX, and GCTK

Should you buy IceCure Medical stock or one of its competitors? IceCure Medical's main competitors and comparable companies include Accuray (ARAY), Inspira Technologies OXY B.H.N. (IINN), Modular Medical (MODD), Inspira Technologies OXY B.H.N. (QTEX), and GlucoTrack (GCTK). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does IceCure Medical compare to Accuray?

Accuray (NASDAQ:ARAY) and IceCure Medical (NASDAQ:ICCM) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, earnings, analyst recommendations, media sentiment, dividends and profitability.

IceCure Medical has lower revenue, but higher earnings than Accuray. Accuray is trading at a lower price-to-earnings ratio than IceCure Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Accuray$401.95M0.07-$49.19M-$0.40N/A
IceCure Medical$3.38M2.17-$15.06M-$8.52N/A

Accuray has a beta of 1.39, meaning that its stock price is 39% more volatile than the broader market. Comparatively, IceCure Medical has a beta of 0.45, meaning that its stock price is 55% less volatile than the broader market.

Accuray has a net margin of -12.24% compared to IceCure Medical's net margin of -427.67%. Accuray's return on equity of -97.85% beat IceCure Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Accuray-12.24% -97.85% -10.82%
IceCure Medical -427.67%-174.26%-112.58%

Accuray presently has a consensus target price of $2.00, suggesting a potential upside of 723.05%. IceCure Medical has a consensus target price of $52.50, suggesting a potential upside of 2,353.27%. Given IceCure Medical's stronger consensus rating and higher probable upside, analysts plainly believe IceCure Medical is more favorable than Accuray.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Accuray
1 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.67
IceCure Medical
2 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.20

In the previous week, IceCure Medical had 5 more articles in the media than Accuray. MarketBeat recorded 6 mentions for IceCure Medical and 1 mentions for Accuray. Accuray's average media sentiment score of 1.87 beat IceCure Medical's score of 0.49 indicating that Accuray is being referred to more favorably in the media.

Company Overall Sentiment
Accuray Very Positive
IceCure Medical Neutral

64.1% of Accuray shares are held by institutional investors. Comparatively, 0.6% of IceCure Medical shares are held by institutional investors. 2.4% of Accuray shares are held by insiders. Comparatively, 2.4% of IceCure Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Accuray and IceCure Medical tied by winning 8 of the 16 factors compared between the two stocks.

How does IceCure Medical compare to Inspira Technologies OXY B.H.N.?

IceCure Medical (NASDAQ:ICCM) and Inspira Technologies OXY B.H.N. (NASDAQ:IINN) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, media sentiment, valuation, risk, earnings, analyst recommendations and profitability.

Inspira Technologies OXY B.H.N. has lower revenue, but higher earnings than IceCure Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IceCure Medical$3.38M2.17-$15.06M-$8.52N/A
Inspira Technologies OXY B.H.N.$289K102.70-$13.22MN/AN/A

IceCure Medical has a beta of 0.45, indicating that its stock price is 55% less volatile than the broader market. Comparatively, Inspira Technologies OXY B.H.N. has a beta of 2.16, indicating that its stock price is 116% more volatile than the broader market.

IceCure Medical currently has a consensus target price of $52.50, suggesting a potential upside of 2,353.27%. Given IceCure Medical's stronger consensus rating and higher possible upside, equities research analysts clearly believe IceCure Medical is more favorable than Inspira Technologies OXY B.H.N..

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
IceCure Medical
2 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.20
Inspira Technologies OXY B.H.N.
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

0.6% of IceCure Medical shares are held by institutional investors. Comparatively, 12.7% of Inspira Technologies OXY B.H.N. shares are held by institutional investors. 2.4% of IceCure Medical shares are held by company insiders. Comparatively, 29.4% of Inspira Technologies OXY B.H.N. shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Inspira Technologies OXY B.H.N. has a net margin of 0.00% compared to IceCure Medical's net margin of -427.67%. Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat IceCure Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
IceCure Medical-427.67% -174.26% -112.58%
Inspira Technologies OXY B.H.N. N/A N/A N/A

In the previous week, IceCure Medical had 6 more articles in the media than Inspira Technologies OXY B.H.N.. MarketBeat recorded 6 mentions for IceCure Medical and 0 mentions for Inspira Technologies OXY B.H.N.. IceCure Medical's average media sentiment score of 0.49 beat Inspira Technologies OXY B.H.N.'s score of 0.00 indicating that IceCure Medical is being referred to more favorably in the media.

Company Overall Sentiment
IceCure Medical Neutral
Inspira Technologies OXY B.H.N. Neutral

Summary

Inspira Technologies OXY B.H.N. beats IceCure Medical on 8 of the 14 factors compared between the two stocks.

How does IceCure Medical compare to Modular Medical?

IceCure Medical (NASDAQ:ICCM) and Modular Medical (NASDAQ:MODD) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, risk, earnings, profitability, institutional ownership, dividends, analyst recommendations and valuation.

IceCure Medical has a beta of 0.45, suggesting that its stock price is 55% less volatile than the broader market. Comparatively, Modular Medical has a beta of 0.45, suggesting that its stock price is 55% less volatile than the broader market.

IceCure Medical has higher revenue and earnings than Modular Medical. Modular Medical is trading at a lower price-to-earnings ratio than IceCure Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IceCure Medical$3.38M2.17-$15.06M-$8.52N/A
Modular MedicalN/AN/A-$28.24M-$8.69N/A

Modular Medical has a net margin of 0.00% compared to IceCure Medical's net margin of -427.67%. IceCure Medical's return on equity of -174.26% beat Modular Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
IceCure Medical-427.67% -174.26% -112.58%
Modular Medical N/A -292.14%-222.79%

In the previous week, IceCure Medical had 4 more articles in the media than Modular Medical. MarketBeat recorded 6 mentions for IceCure Medical and 2 mentions for Modular Medical. IceCure Medical's average media sentiment score of 0.49 beat Modular Medical's score of 0.41 indicating that IceCure Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
IceCure Medical
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Modular Medical
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

0.6% of IceCure Medical shares are owned by institutional investors. Comparatively, 27.5% of Modular Medical shares are owned by institutional investors. 2.4% of IceCure Medical shares are owned by company insiders. Comparatively, 7.1% of Modular Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

IceCure Medical currently has a consensus target price of $52.50, suggesting a potential upside of 2,353.27%. Given IceCure Medical's stronger consensus rating and higher probable upside, research analysts plainly believe IceCure Medical is more favorable than Modular Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
IceCure Medical
2 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.20
Modular Medical
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

IceCure Medical beats Modular Medical on 11 of the 14 factors compared between the two stocks.

How does IceCure Medical compare to Inspira Technologies OXY B.H.N.?

IceCure Medical (NASDAQ:ICCM) and Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their dividends, valuation, earnings, analyst recommendations, media sentiment, profitability, institutional ownership and risk.

Inspira Technologies OXY B.H.N. has lower revenue, but higher earnings than IceCure Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IceCure Medical$3.38M2.17-$15.06M-$8.52N/A
Inspira Technologies OXY B.H.N.$290K101.45-$13.22MN/AN/A

Inspira Technologies OXY B.H.N. has a net margin of 0.00% compared to IceCure Medical's net margin of -427.67%. Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat IceCure Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
IceCure Medical-427.67% -174.26% -112.58%
Inspira Technologies OXY B.H.N. N/A N/A N/A

IceCure Medical has a beta of 0.45, meaning that its share price is 55% less volatile than the broader market. Comparatively, Inspira Technologies OXY B.H.N. has a beta of 4.24, meaning that its share price is 324% more volatile than the broader market.

0.6% of IceCure Medical shares are held by institutional investors. Comparatively, 12.7% of Inspira Technologies OXY B.H.N. shares are held by institutional investors. 2.4% of IceCure Medical shares are held by company insiders. Comparatively, 29.4% of Inspira Technologies OXY B.H.N. shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, IceCure Medical had 5 more articles in the media than Inspira Technologies OXY B.H.N.. MarketBeat recorded 6 mentions for IceCure Medical and 1 mentions for Inspira Technologies OXY B.H.N.. Inspira Technologies OXY B.H.N.'s average media sentiment score of 1.89 beat IceCure Medical's score of 0.49 indicating that Inspira Technologies OXY B.H.N. is being referred to more favorably in the news media.

Company Overall Sentiment
IceCure Medical Neutral
Inspira Technologies OXY B.H.N. Very Positive

IceCure Medical currently has a consensus target price of $52.50, indicating a potential upside of 2,353.27%. Given IceCure Medical's stronger consensus rating and higher probable upside, analysts plainly believe IceCure Medical is more favorable than Inspira Technologies OXY B.H.N..

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
IceCure Medical
2 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.20
Inspira Technologies OXY B.H.N.
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

Inspira Technologies OXY B.H.N. beats IceCure Medical on 9 of the 14 factors compared between the two stocks.

How does IceCure Medical compare to GlucoTrack?

GlucoTrack (NASDAQ:GCTK) and IceCure Medical (NASDAQ:ICCM) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, analyst recommendations, valuation, profitability, dividends, risk, media sentiment and institutional ownership.

IceCure Medical has a consensus price target of $52.50, indicating a potential upside of 2,353.27%. Given IceCure Medical's stronger consensus rating and higher possible upside, analysts clearly believe IceCure Medical is more favorable than GlucoTrack.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
GlucoTrack
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
IceCure Medical
2 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.20

GlucoTrack has a beta of 0.62, meaning that its share price is 38% less volatile than the broader market. Comparatively, IceCure Medical has a beta of 0.45, meaning that its share price is 55% less volatile than the broader market.

10.9% of GlucoTrack shares are held by institutional investors. Comparatively, 0.6% of IceCure Medical shares are held by institutional investors. 5.9% of GlucoTrack shares are held by insiders. Comparatively, 2.4% of IceCure Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

IceCure Medical has higher revenue and earnings than GlucoTrack. IceCure Medical is trading at a lower price-to-earnings ratio than GlucoTrack, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
GlucoTrackN/AN/A-$19.39M-$137.63N/A
IceCure Medical$3.38M2.17-$15.06M-$8.52N/A

GlucoTrack has a net margin of 0.00% compared to IceCure Medical's net margin of -427.67%. IceCure Medical's return on equity of -174.26% beat GlucoTrack's return on equity.

Company Net Margins Return on Equity Return on Assets
GlucoTrackN/A -2,135.52% -290.22%
IceCure Medical -427.67%-174.26%-112.58%

In the previous week, IceCure Medical had 4 more articles in the media than GlucoTrack. MarketBeat recorded 6 mentions for IceCure Medical and 2 mentions for GlucoTrack. GlucoTrack's average media sentiment score of 1.03 beat IceCure Medical's score of 0.49 indicating that GlucoTrack is being referred to more favorably in the media.

Company Overall Sentiment
GlucoTrack Positive
IceCure Medical Neutral

Summary

IceCure Medical beats GlucoTrack on 9 of the 15 factors compared between the two stocks.

Get IceCure Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for ICCM and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ICCM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ICCM vs. The Competition

Export
MetricIceCure MedicalHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$7.23M$5.58B$7.21B$12.81B
Dividend YieldN/A1.78%2.56%10.55%
P/E Ratio-0.2524.44272.8225.11
Price / Sales2.1772.59620.9490.53
Price / CashN/A32.6977.3351.83
Price / Book0.585.8910.436.18
Net Income-$15.06M$150.94M$3.49B$358.18M
7 Day Performance-4.04%-3.02%-3.16%-2.51%
1 Month Performance-39.03%-3.88%0.02%-2.73%
1 Year Performance-92.82%5.61%17.34%7.73%

IceCure Medical Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ICCM
IceCure Medical
2.9511 of 5 stars		$2.14
+1.4%		$52.50
+2,353.3%		-92.9%$7.23M$3.38MN/A60
ARAY
Accuray
2.52 of 5 stars		$0.25
-3.2%		$2.00
+685.5%		-84.3%$30.41M$401.95MN/A1,040
IINN
Inspira Technologies OXY B.H.N.
N/A$0.83
-0.8%		N/A-34.0%$29.74M$289KN/A20
MODD
Modular Medical
0.9281 of 5 stars		$3.56
-5.3%		N/A-87.3%$29.01MN/AN/A20
QTEX
Inspira Technologies OXY B.H.N.
0.5846 of 5 stars		$0.80
-3.5%		N/AN/A$28.71M$290KN/A20

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:ICCM) was last updated on 9/11/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
The end may be near for these iconic stocks
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...
Chaikin Analytics | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel